Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 2Phase 1/2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Liver Neoplasms 3Carcinoma, Hepatocellular 3Colorectal Neoplasms 2Neoplasms 1Neoplasm Metastasis 1Hypertension, Portal 1Gallbladder Neoplasms 1Fibrosis 1Colonic Neoplasms 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Bevacizumab 234Fluorouracil 220Oxaliplatin 216Irinotecan 215Leucovorin 199Capecitabine 153Cetuximab 146Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15Biopsy 15apatinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × Liver Transplantation × Clear all
NCT04898504 2024-11-07

EXCALIBUR1+2

Oslo University Hospital

Phase 2 Active not recruiting
45 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03803436 2023-03-16

COLT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
22 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡